These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 29172759)

  • 1. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
    Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
    Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment.
    Xu Y; Liu D; Hu J; Ding P; Chen M
    Int J Pharm; 2020 Jan; 573():118637. PubMed ID: 31550511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
    Wang S; Zhang J; Wang Y; Chen M
    Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
    Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
    Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
    Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
    Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
    Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 targeted redox-triggered self-assembly with magnetic enhanced EPR effects for effective amplification of gambogic acid to treat triple-negative breast cancer.
    Sang M; Han L; Luo R; Qu W; Zheng F; Zhang K; Liu F; Xue J; Liu W; Feng F
    Biomater Sci; 2019 Dec; 8(1):212-223. PubMed ID: 31674634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-modified carboxymethyl-chitosan/polyethylenimine/bovine serum albumin based complexes for tumor site-specific drug delivery.
    Zhang Y; Tan X; Ren T; Jia C; Yang Z; Sun H
    Carbohydr Polym; 2018 Oct; 198():76-85. PubMed ID: 30093044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.
    Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y
    Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles.
    Mohammad Gholinia Sarpoli L; Zare-Karizi S; Heidari E; Hasanzadeh A; Bayandori M; Azedi F; Hamblin MR; Karimi M
    Pharm Dev Technol; 2022 Sep; 27(7):785-793. PubMed ID: 36043390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
    Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
    Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
    Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium.
    Bivas-Benita M; Romeijn S; Junginger HE; Borchard G
    Eur J Pharm Biopharm; 2004 Jul; 58(1):1-6. PubMed ID: 15207531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway.
    Li J; Zhang J; Wang Y; Liang X; Wusiman Z; Yin Y; Shen Q
    Int J Pharm; 2017 May; 523(1):300-309. PubMed ID: 28336457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Targeting of Differentiated Breast Cancer Cells and Breast Cancer Stem Cells by Combination of Docetaxel- and Sulforaphane-Loaded Self-Assembled Poly(D, L-lactide-co-glycolide)/Hyaluronic Acid Block Copolymer-Based Nanoparticles.
    Huang J; Tao C; Yu Y; Yu F; Zhang H; Gao J; Wang D; Chen Y; Gao J; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Zou H; Xu H; Lu Y; Zhong Y
    J Biomed Nanotechnol; 2016 Jul; 12(7):1463-77. PubMed ID: 29337484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
    Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
    Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line.
    Byrne CE; Astete CE; Vaithiyanathan M; Melvin AT; Moradipour M; Rankin SE; Knutson BL; Sabliov CM; Martin EC
    Nanomedicine (Lond); 2020 Apr; 15(10):981-1000. PubMed ID: 32238059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.